08:36 AM EDT, 08/28/2025 (MT Newswires) -- EUDA Health ( EUDA ) shares gained nearly 5% in Thursday premarket trading after the company said it signed a letter of intent to carry out due diligence regarding a potential acquisition of Chemokine, a Singapore based biotech firm.

EUDA Health ( EUDA ) said Chemokine has agreed to an exclusivity period of at least 120 days, during which it would not hold talks with any other entity regarding an acquisition.